We would like to congratulate Kam Pooni, CEO at Glyconics, a Deepbridge Life Sciences EIS investee company, for being identified as one of the ‘pioneers’ of the European startup world, as selected by Sifted.eu (backed by the Financial Times).

With the dramatic impact Coronavirus has had on the world, society is adjusting, priorities are shifting, and companies are transforming – including the European startup ecosystem.

Sectors such as consumer health, education, remote working, ecommerce and logistics (to name just a few) might never be the same again.

Glyconcis were identified within the ‘health category’, which Sifted identify as the firms, projects and initiatives aiming to crack the next healthcare codes with technology.

The full list can be found here. 

By following this link, you will leave the Deepbridge website. Deepbridge takes no responsibility for content on external websites. 

To find out more about Glyconics please click here.